Terence Wong
Overview:
1. Anatomic/functional oncologic Imaging: SPECT/CT, PET/CT, novel PET radiotracers
2. Radiotheranostics, Radionuclide therapy of cancer, Radiation Therapy Planning
3. Imaging biomarkers for guiding treatment strategies
4. Multicenter clinical trial development (NCI National Clinical Trials Network)
2. Radiotheranostics, Radionuclide therapy of cancer, Radiation Therapy Planning
3. Imaging biomarkers for guiding treatment strategies
4. Multicenter clinical trial development (NCI National Clinical Trials Network)
Positions:
Professor of Radiology
Radiology, Nuclear Medicine
School of Medicine
Professor in Medicine
Medicine, Medical Oncology
School of Medicine
Member of the Duke Cancer Institute
Duke Cancer Institute
School of Medicine
Education:
M.D. 1990
Dartmouth College
Ph.D. 1990
Dartmouth College
Residency, Diagnostic Radiology
Beth Israel Deaconess Medical Center
Fellowship, Nuclear Radiology
Beth Israel Deaconess Medical Center
Fellowship, Body Imaging
Beth Israel Deaconess Medical Center
Grants:
Phase II Study of 44Gy from 131I-81C6 for CNS Tumors
Administered By
Neurosurgery, Neuro-Oncology
Awarded By
National Institutes of Health
Role
Co Investigator
Start Date
End Date
Radiation-Induced Cardiopulmonary Injury in Humans
Administered By
Radiation Oncology
Awarded By
National Institutes of Health
Role
Investigator
Start Date
End Date
Predicting Human Tumor Response by 31p MRS
Administered By
Radiology, Neuroradiology
Awarded By
National Institutes of Health
Role
Co Investigator
Start Date
End Date
Simultaneous Emission and Transmission Mammotomography
Administered By
Radiology
Awarded By
National Institutes of Health
Role
Investigator
Start Date
End Date
ECOG-ACRIN Operations Center Grant
Administered By
Radiology, Nuclear Medicine
Awarded By
American College of Radiology Imaging Network
Role
Principal Investigator
Start Date
End Date
Publications:
Hybrid PET/MR: State-of-the-Art and Future Challenges.
MLA Citation
Lin, Weili, et al. “Hybrid PET/MR: State-of-the-Art and Future Challenges.” Magn Reson Imaging Clin N Am, vol. 25, no. 2, May 2017, pp. xv–xvii. Pubmed, doi:10.1016/j.mric.2017.02.001.
URI
https://scholars.duke.edu/individual/pub1431929
PMID
28390538
Source
pubmed
Published In
Magn Reson Imaging Clin N Am
Volume
25
Published Date
Start Page
xv
End Page
xvii
DOI
10.1016/j.mric.2017.02.001
Neurosurgical Procedures Monitored by Intraoperative MRI
Authors
Wong, TZ; Schwartz, RB; Nabavi, A; Pergolizzi, RS; Black, PM; Alexander, E; Martin, CH; Jolesz, FA
MLA Citation
Wong, T. Z., et al. “Neurosurgical Procedures Monitored by Intraoperative MRI.” Emagres, vol. 2007, Jan. 2007. Scopus, doi:10.1002/9780470034590.emrstm0341.
URI
https://scholars.duke.edu/individual/pub1507367
Source
scopus
Published In
Emagres
Volume
2007
Published Date
DOI
10.1002/9780470034590.emrstm0341
Pilot Study of [18F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC).
INTRODUCTION: Computed tomography (CT) has limited diagnostic accuracy for staging of muscle-invasive bladder cancer (MIBC). [18F] Fluorodeoxyglucose positron emission tomography (FDG-PET)/magnetic resonance imaging (MRI) is a novel imaging modality incorporating functional imaging with improved soft tissue characterization. This pilot study evaluated the use of preoperative FDG-PET/MRI for staging of MIBC. PATIENTS AND METHODS: Twenty-one patients with MIBC with planned radical cystectomy were enrolled. Two teams of radiologists reviewed FDG-PET/MRI scans to determine: (1) presence of primary bladder tumor; and (2) lymph node involvement and distant metastases. FDG-PET/MRI was compared with cystectomy pathology and computed tomography (CT). RESULTS: Eighteen patients were included in the final analysis, most (72.2%) of whom received neoadjuvant chemotherapy. Final pathology revealed 10 (56%) patients with muscle invasion and only 3 (17%) patients with lymph node involvement. Clustered analysis of FDG-PET/MRI radiology team reads revealed a sensitivity of 0.80 and a specificity of 0.56 for detection of the primary tumor with a sensitivity of 0 and a specificity of 1.00 for detection of lymph node involvement when compared with cystectomy pathology. CT imaging demonstrated similar rates in evaluation of the primary tumor (sensitivity, 0.91; specificity, 0.43) and lymph node involvement (sensitivity, 0; specificity, 0.93) when compared with pathology. CONCLUSIONS: This pilot single-institution experience of FDG-PET/MRI for preoperative staging of MIBC performed similar to CT for the detection of the primary tumor; however, the determination of lymph node status was limited by few patients with true pathologic lymph node involvement. Further studies are needed to evaluate the potential role for FDG-PET/MRI in the staging of MIBC.
Authors
MLA Citation
Eulitt, Patrick J., et al. “Pilot Study of [18F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC).” Clin Genitourin Cancer, vol. 18, no. 5, Oct. 2020, pp. 378-386.e1. Pubmed, doi:10.1016/j.clgc.2020.02.008.
URI
https://scholars.duke.edu/individual/pub1434765
PMID
32147364
Source
pubmed
Published In
Clin Genitourin Cancer
Volume
18
Published Date
Start Page
378
End Page
386.e1
DOI
10.1016/j.clgc.2020.02.008
Utility of Deep Inspiration Breath Hold for Left-Sided Breast Radiation Therapy in Preventing Early Cardiac Perfusion Defects: A Prospective Study.
PURPOSE: To evaluate early cardiac single photon computed tomography (SPECT) findings after left breast/chest wall postoperative radiation therapy (RT) in the setting of deep inspiration breath hold (DIBH). METHODS AND MATERIALS: We performed a prospective single-institution single-arm study of patients who were planned for tangential RT with DIBH to the left breast/chest wall (± internal mammary nodes). The DIBH was done by use of a controlled surface monitoring technique (AlignRT, Vision RT Ltd, London, UK). The RT was given with tangential fields and a heart block. Radiation-induced cardiac perfusion and wall motion changes were assessed by pre-RT and 6-month post-RT SPECT scans. A cumulative SPECT summed-rest score was used to quantify perfusion in predefined left ventricle segments. The incidence of wall motion abnormalities was assessed in each of these same segments. RESULTS: A total of 20 patients with normal pre-RT scans were studied; their median age was 56 years (range, 39-72 years). Seven (35%) patients also received irradiation to the left internal mammary chain, and 5 (25%) received an additional RT field to supraclavicular nodes. The median heart dose was 94 cGy (range, 56-200 cGy), and the median V25Gy was zero (range, 0-0.1). None of the patients had post-RT perfusion or wall motion abnormalities. CONCLUSIONS: Our results suggest that DIBH and conformal cardiac blocking for patients receiving tangential RT for left-sided breast cancer is an effective means to avoid early RT-associated cardiac perfusion defects.
Authors
MLA Citation
Zagar, Timothy M., et al. “Utility of Deep Inspiration Breath Hold for Left-Sided Breast Radiation Therapy in Preventing Early Cardiac Perfusion Defects: A Prospective Study.” Int J Radiat Oncol Biol Phys, vol. 97, no. 5, 2017, pp. 903–09. Pubmed, doi:10.1016/j.ijrobp.2016.12.017.
URI
https://scholars.duke.edu/individual/pub1293360
PMID
28333011
Source
pubmed
Published In
Int J Radiat Oncol Biol Phys
Volume
97
Published Date
Start Page
903
End Page
909
DOI
10.1016/j.ijrobp.2016.12.017
A phase II/III study of perioperative nivolumab and ipilimumab in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: A trial of the ECOG-ACRIN Cancer Research Group (EA2174).
Authors
MLA Citation
Eads, Jennifer Rachel, et al. “A phase II/III study of perioperative nivolumab and ipilimumab in patients (pts) with locoregional esophageal (E) and gastroesophageal junction (GEJ) adenocarcinoma: A trial of the ECOG-ACRIN Cancer Research Group (EA2174).” Journal of Clinical Oncology, vol. 38, no. 15, 2020.
URI
https://scholars.duke.edu/individual/pub1476202
Source
wos-lite
Published In
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Volume
38
Published Date
Research Areas:
Diagnostic Imaging
Imaging, Three-Dimensional
Molecular Imaging
Radionuclide Imaging

Professor of Radiology
Contact:
Box 3949 Med Ctr, Durham, NC 27710
Dept of Radiology, DIV of Nucl, Dmp Room 1W18, Durham, NC 27710